Kimia Biosciences (BOM:530313) Shareholder Yield % : 0.00% (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530313 Kimia Biosciences Ltd BOM:530313
23 GF Score
Price ₹28.79
View Full Analysis

What is Kimia Biosciences Shareholder Yield %?

Kimia Biosciences BOM:530313 +5.57% 23 Shareholder Yield % is 0.00% as of . 20. GuruFocus rates BOM:530313 with a GF Score™ of 23/100. Among 971 Drug Manufacturers companies, Kimia Biosciences ranks worse than 102986.51% on this metric.

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return. Kimia Biosciences does not have enough data to calculate Shareholder Yield %.


Kimia Biosciences  (BOM:530313) Shareholder Yield % Explanation

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."

Shareholder Yield % is calculated by three components: Dividend Yield %, Buyback Yield %, and Net Debt Paydown Yield %.

Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.

Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.


Kimia Biosciences Shareholder Yield % Related Terms


Kimia Biosciences Shareholder Yield % Historical Data

* Premium members only.

The historical data trend for Kimia Biosciences's Shareholder Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kimia Biosciences Shareholder Yield % Chart

Kimia Biosciences Annual Data
Trend
Shareholder Yield %

Kimia Biosciences Semi-Annual Data
Shareholder Yield %

BOM:530313 vs ZTS: Shareholder Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kimia Biosciences Shareholder Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's Shareholder Yield % distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's Shareholder Yield % falls into.


BOM:530313
23GF Score
Kimia Biosciences Ltd BOM:530313
Shareholder Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kimia Biosciences Shareholder Yield % Calculation

Kimia Biosciences's Shareholder Yield % for the quarter that ended in . 20 is calculated as:

Shareholder Yield %=Dividend Yield %+Buyback Yield %+Net Debt Paydown Yield %
= %+ %+ %
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

Frequently Asked Questions Learn more about Shareholder Yield % →
What does a Shareholder Yield % of 0.00% mean?
Kimia Biosciences (BOM:530313) has a Shareholder Yield % of 0.00% as of . 20. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Kimia Biosciences and its competitors. According to the industry distribution chart, Kimia Biosciences ranks #999999 out of 971 companies in the Drug Manufacturers industry.
Is Kimia Biosciences' Shareholder Yield % too high?
Kimia Biosciences' current Shareholder Yield % is 0.00%. Based on the distribution chart, Kimia Biosciences ranks #999999 out of 971 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Kimia Biosciences has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Kimia Biosciences' Shareholder Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Kimia Biosciences ranks #999999 out of 971 companies for Shareholder Yield %. This places Kimia Biosciences in the lower half of its industry. The industry median Shareholder Yield % is 0.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Drug Manufacturers company?
The median Shareholder Yield % among Drug Manufacturers companies is 0.29, based on 971 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Kimia Biosciences and its competitors. For the Drug Manufacturers industry, the median Shareholder Yield % is 0.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kimia Biosciences's current Shareholder Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kimia Biosciences stock overvalued right now?
Kimia Biosciences (BOM:530313) has a current Shareholder Yield % of 0.00%. The current Shareholder Yield % is 0.00%. Kimia Biosciences' overall GF Score™ is 23/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Kimia Biosciences (BOM:530313), the current Shareholder Yield % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kimia Biosciences Business Description

Address Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Prucalopride, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.
23GF Score

Get the complete analysis for BOM:530313

Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹28.79
Price